Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: dengue virus

April 21, 2026 Drug delivery / Pharma applications

CD in prevention of dengue-induced lethality

Annexin A1 (AnxA1) was identified as an endogenous regulator of inflammation in dengue. Treatment with the AnxA1 peptidomimetic, Ac2-26, improved

Continue reading

March 18, 2021 CD as API / CD derivatives / Pharma applications

First results on cyclodextrins against dengue fever from CycloLab

In May, 2020, CycloLab announced a collaboration, where University of California, Berkeley, Excivion and CycloLab teamed-up to evaluate the antiviral

Continue reading

January 30, 2020 CD as API / CD derivatives / Pharma applications

Modified cyclodextrins as broad-spectrum antivirals

The recent paper of Swiss and English researchers on modified cyclodextrins as antiviral agents received great attention in the bulvar.

Continue reading

Recent Posts

  • Multiscale mechanistic analysis of reversible cross-linking polymers based on host–guest interactions
  • Redox responsive cyclodextrin-based drug delivery systems: a special insight to glutathione responsive CD-nanosponges
  • CD in prevention of dengue-induced lethality
  • A Bubble-Driven Drug Delivery System Enhances Oral Absorption and Antipyretic Efficacy of Poorly Water-Soluble Andrographolide
  • Improving Drug Bioavailability with Cyclodextrin Complexes: An integrative meta-modeling approach

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (64)
  • CD as API (341)
  • CD derivatives (399)
  • Cosmetics and toilettry (49)
  • Diagnosis (12)
  • Drug delivery (780)
  • E-ducation (63)
  • Environmental (131)
  • Events (232)
  • Food (217)
  • Gene delivery (19)
  • Household products (1)
  • Household products (4)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (392)
  • Other industrial use (104)
  • Pharma applications (1,166)
  • Supramolecular systems (40)
  • Uncategorized (140)

Top Posts

  • MIT scientists filed patent for HPBCD treatment in Alzheimer's disease
  • Multiscale mechanistic analysis of reversible cross-linking polymers based on host–guest interactions
  • Redox responsive cyclodextrin-based drug delivery systems: a special insight to glutathione responsive CD-nanosponges
  • Supramolecular Nanomedicine for Cancer: Research, Collaboration, and Dialogue - First Online Workshop of the NextNano4Cancer project
  • Intelligent Drug design Platforms in Cancer Research (online workshop from Taipei University)
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • Comparative evaluation of lyophilized voriconazole formulations marketed in European Union
  • Nobel Prize winner in 2016 for Chemistry, Sir James Fraser Stoddart at ICS 20
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Lanosterol eye drops for cataract treatment

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,795 other subscribers
 

Loading Comments...